Key points

Serena Williams’ support for GLP-1 drugs claims to reduce stigma yet implies weight-loss must be “earned.”

Drug costs for non-medically-necessary weight loss can be very high, so many cannot afford them.

This combination of ideas and barriers will make "staying fat" even more stigmatized.

This week, Elle magazine published an interview with Serena Williams, in which she revealed and explained her use of GLP-1 drugs for her recent weight loss. She is a famous tennis champion, but also a brand ambassador for one of the emerging telehealth companies that is making Ozempic, Zepbound, and similar medications more readily available for “off-label” use. These online businesses are particularly serving those, like Williams, who may not clinically be defined as “obese” but stil

See Full Page